Expression of non-muscle myosin (NM) IIC in skeletal muscle cells. by Hiroki Hamaguchi (22783780)

Subjects:

Frequency of hypoglycemic episodes in group 1 vs group 2. by Nadia Gul (249538)

Subjects:

Demographics and baseline characteristics of patients. by Nadia Gul (249538)

Subjects:

Comparison of soleus muscle weight and fiber size histogram between young and aged WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Subjects:

Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. by Nadia Gul (249538)

Subjects:

Loss of Vps34 reduces Treg suppressive function and is associated with the development of type-I-dominant inflammatory disease. by Erienne G. Norton (9612079)

Demographic data of female participants (n = 30). by Vanessa Wellauer (18408477)

Subjects:

Results of physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Results of recovery parameters. by Vanessa Wellauer (18408477)

Subjects:

Raw data used for statistical analysis. by Vanessa Wellauer (18408477)

Subjects:

Schematic representation of the experimental protocol over time. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

CONSORT flowchart of participants. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for recovery parameter. by Vanessa Wellauer (18408477)

Subjects:

The table shows the significant and non-significant altered group with different parameters. by Ashraf Attia Mahmoud (21262201)

Subjects:

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

Summary of previous work. by Junyan Wang (4738518)

Subjects:

Comparison of MAP@0.5 results from experiments. by Junyan Wang (4738518)

Subjects:

YOLO11. by Junyan Wang (4738518)

Subjects:

Structure of the SCI-YOLO11 network. by Junyan Wang (4738518)

Subjects: